Doxazosin mesylate
- Product NDC
- 59762-1389
- 11-digit product format
- 597621389
- Labeler code
- 59762
- Product ID
- 59762-1389_af51b645-f7da-4e48-84b3-59bcc153937b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- doxazosin mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Mylan Pharmaceuticals Inc.
- Application
- NDA019668
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start
- 2025-05-09
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin mesylate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197625, 197626, 197627, 197628 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 59762-1389-7 | Doxazosin mesylate | 100 in 1 BOTTLE | TABLET | 100 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 59762-1389 | DOXAZOSIN MESYLATE TABLET [MYLAN PHARMACEUTICALS INC.] | 1 | Current NDC, 1 package rows | 20250511_2e524986-7903-416f-b2b8-d27295103e75.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 59762-1389-7 | 59762138907 | 100 in 1 BOTTLE | Historical |